Canadian chemical industry news

• 

  26 March 2026

  ADNOC and OMV appoint executive team for Borouge Group International AG

  Roger Kearns, Dr. Stefan Doboczky and Dr. Hasan Karam to lead; interim CFO until May 2026; supervisory board set; deal on track to close by end‑March 2026, forming a global polyolefins leader
• 

  26 March 2026

  OMV and ADNOC appoint Borouge Group International AG executive team

  Appointed CEO Roger Kearns, CCO Dr. Stefan Doboczky, COO Dr. Hasan Karam; interim CFO Daniel Turnheim until May 2026. Appointments precede planned combination and acquisition closing by Mar 2026.
• 

  19 March 2026

  ADNOC and OMV advance formation of Borouge Group International AG

  Agreement allows marketing of B4 volumes, adds ~$400M net over 3 years (~10% EPS accretion), supports 16.2 fils dividend, targets strong credit ratings; transactions close ~Mar 2026.
• 

  19 March 2026

  GSK: Lynavoy (linerixibat) FDA-approved for cholestatic pruritus in PBC

  FDA approved linerixibat for cholestatic pruritus in adults with PBC after GLISTEN phase III showed rapid, sustained itch and sleep improvements. Common AEs: diarrhea, abdominal pain.
• 

  19 March 2026

  Clariant opens pharma-grade PEG manufacturing plant in Texas

  GMP-compliant excipient production strengthens supply-chain resilience, shortens lead times, and improves continuity and traceability for pharma customers across North & Latin America.
• 

  17 March 2026

  Kemira obtains PMRA approval in Canada for KemConnect DEX

  Chlorine-free performic-acid wastewater disinfection; used in Paris 2024 wastewater works. Combines on-site generation, real-time monitoring and dosing algorithm. Canada rollout pending approvals

• 

  17 March 2026

  BASF Agricultural Solutions invests €17M to expand Saskatoon canola breeding centre

  Construction 2026–2027 adds automation, genomic-selection pipelines and a research glasshouse to boost breeding throughput, speed genetic gain and deliver higher-yield, disease-resistant hybrids
• 

  16 March 2026

  OCI Sells Methanex Shares

  OCI sold 3.3 million Methanex shares for $172.6 million, reducing its stake from 12.9% to 8.6%. Future transactions depend on market conditions and Methanex's performance.
• 

  12 March 2026

  Evonik and IMCD Expand U.S. Distribution for VISIOMER® Methacrylates

  IMCD will distribute VISIOMER® Specialty Methacrylates in the U.S., enhancing support for coatings, adhesives, construction, and more.
• 

  11 March 2026

  Elkem Restructures and Cuts Costs to Boost Competitiveness

  Elkem introduces a new structure, reduces workforce by 300, and cuts costs by NOK 1.9 billion to enhance profitability amid market challenges.
• 

  9 March 2026

  Shell Sells Jiffy Lube and Premium Velocity Auto to Monomoy Capital Partners

  Shell sells Jiffy Lube and Premium Velocity Auto for $1.3B, retaining other lubricant brands. A long-term supply agreement is included. Closing expected in H2 2026, pending approvals.
• 

  9 March 2026

  GSK and Alfasigma License Agreement for Linerixibat Rights

  Alfasigma gains global rights to develop and market linerixibat for cholestatic pruritus in PBC. GSK to receive payments and royalties. Regulatory reviews are ongoing.
• 

  6 March 2026

  TotalEnergies Releases Independent Review of Tilenga Project Land Acquisition in Uganda

  The assessment confirms compliance with land acquisition standards. An action plan addresses livelihood restoration, support for vulnerable households, grievance management, and gender considerations.
• 

  6 March 2026

  Silox Acquires BASF's Hydrosulfite Assets

  Silox strengthens its position in paper and textile industries by acquiring BASF's hydrosulfite assets, enhancing service to European customers and expanding global market presence.
• 

  3 March 2026

  Dow Receives CAD $1.62 Billion from NOVA After Court Decision

  Dow received CAD $1.8 billion, including damages and costs, after NOVA's appeal was denied. The payment is subject to tax withholding, expected to be refunded by year-end.
• 

  2 March 2026

  EIB and Canada Collaborate on Raw Material Resilience

  A Letter of Intent was signed to enhance cooperation on critical raw materials, aiming to secure sustainable supply chains for Europe's green and digital transitions.
• 

  2 March 2026

  thyssenkrupp Uhde to Study Biomass-to-Methanol Integration for Nova Sustainable Fuels in Canada

  The study will assess the integration of gasification and methanol synthesis to produce 450,000 metric tons of bio-methanol annually, aiding decarbonization in transportation and shipping.
• 

  26 February 2026

  GSK's Linerixibat Gets Priority Review in China for PBC-Related Itch

  Linerixibat shows significant improvement in cholestatic pruritus in PBC patients, based on GLISTEN phase III trial data. Regulatory reviews ongoing in US, EU, UK, and Canada.
• 

  25 February 2026

  Vopak Announces Record 2025 Results and EUR 1.7 Billion Shareholder Program

  Net profit rose 61% to EUR 604M. Operating cash flow hit EUR 823M. EUR 4B investment by 2030 planned. EUR 1.1B in growth projects underway. Energy transition projects worth EUR 200M in progress.
• 

  19 February 2026

  Merck Reports Positive Phase 3 Trial Results for ENFLONSIA in High-Risk Infants and Children

  ENFLONSIA shows consistent safety and efficacy in high-risk infants over two RSV seasons, supporting expanded use for children under 2.
• 

  27 January 2026

  Moeve Reduces Fresh Water Use by 21% in Spanish Industrial Parks Since 2019

  Moeve plans a 25% water reduction by 2028, expanding efforts to Brazil, Canada, and China, while maintaining top water management ratings.
• 

  22 January 2026

  Enerkem Promotes Alex Miles to VP, Commercial Development

  Alex Miles will lead global business development, focusing on project growth and strategic agreements, leveraging his 15+ years in renewable infrastructure.
• 

  20 January 2026

  Aspect Biosystems and Novo Nordisk Advance Partnership for Diabetes Medicines

  The partnership focuses on developing cellular therapies for diabetes, integrating technologies, and expanding manufacturing and R&D capabilities across Canada, the US, and Denmark.
• 

  20 January 2026

  Moderna and Merck Report 5-Year Data on Intismeran Autogene with KEYTRUDA

  Intismeran autogene with KEYTRUDA shows 49% reduced risk of recurrence or death in high-risk melanoma over five years. Further data to be presented at a future medical conference.
• 

  23 December 2025

  Grupa Azoty Secures Potash Agreement

  Grupa Azoty signed a potash supply deal with Nutrien, ensuring stable quality and supply for NPK fertilizers until 2027.
• 

  12 December 2025

  PPG Announces Leadership Changes

  Adriana Macouzet to retire in 2026. Jennifer Solcz and Javier Sosa Mejía will assume expanded roles in protective, marine, and architectural coatings across the Americas.
• 

  11 December 2025

  Roche Secures CE Mark for Broadest Automated Mass Spectrometry IVD Menu

  Roche's automated mass spectrometry platform now offers 39 tests, enhancing lab efficiency and supporting faster, precise diagnoses, including antibiotic monitoring.
• 

  9 December 2025

  Fluor Secures Contract for Teck's Highland Valley Copper Mine Extension

  The project extends the mine's life to 2046, involving upgrades to systems and facilities, creating 2,900 local jobs during construction.
• 

  8 December 2025

  Fluor JV Completes Second LNG Train for LNG Canada

  Fluor and JGC complete Train 2 of LNG Canada, marking the first phase's end. The project emphasizes safety, environmental focus, and Indigenous economic engagement.
• 

  6 November 2025

  Novo Nordisk's CagriSema Reduces Blood Pressure and Inflammation, Lowers Heart Disease Risk

  CagriSema shows potential in reducing blood pressure, inflammation, and heart disease risk, with ongoing trials to assess cardiovascular outcomes.